Altogether, these results further consolidate a novel mechanism that deubiquitinase USP39 and E3 ligase TRIM26 function in an antagonistic pattern and play key roles in controlling ZEB1 stability to determine the HCC progression. The gene discussed is TRIM26; the disease is hepatocellular carcinoma.